The following tables list new pharmaceutical account wins notified to us by the winning
agencies for the period March 2006 to May 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
|
| |
|
The Alliance for Better Bone (P&G; S-A) |
Actonel |
Osteoporosis |
Ketchum |
ABPI |
The Involved Patient Initiative |
N/A |
Shire Health London |
Altana Pharma |
Pantoprazole |
Gastrointestinal |
Shire Health London |
Apitope Technology |
Phase Ib/IIa therapeutic biological vaccine |
MS |
Healthcare Solutions |
AstraZeneca |
Crestor |
Cardiovascular |
Zaicom MMC |
GlaxoSmithKline |
HPV vaccine |
Gynaecology/oncology |
Succinct Communications |
GlaxoSmithKline |
Telzir |
HIV |
90TEN Healthcare |
GrÈnenthal International |
Transtec - publications planning |
Pain |
Zaicom MMC |
Kimberly-Clark |
InteguSeal |
Antimicrobial surgical skin preparation |
De Facto Medica |
Link Pharmaceuticals |
Gliadel implant |
Oncology |
Spink Consumer Relations |
Merck SantÈ |
Glucovance |
Type II diabetes |
De Facto Medica |
NICE |
At Ri-SK? awareness campaign |
Solar keratosis |
hsdcommunications |
NICE |
Quick Reference Guides |
N/A |
90TEN Healthcare |
Pfizer |
Oncology portfolio |
Managed entry |
Succinct Communications |
Plethora/Timm |
Osbon ErecAid |
Male sexual dysfunction |
De Facto Medica |
ProStrakan |
Rapinyl |
Breakthrough pain |
Litmus/CCA |
Recordati |
Zanidip |
Cardiology |
LeapFrog Medical Communications |
Roche Pharmaceuticals |
Fuzeon/Invirase |
HIV |
Aurora |
Schering-Plough |
Nasonex |
Respiratory disease |
LeapFrog Medical Communications |
Servier |
Various |
Cardiology |
Zaicom MMC |
Speedel |
SPP301 |
Hypertension |
De Facto Medica |
UCB |
Professional development programme |
ADHD |
Huntsworth Health Avenue |
Wyeth Consumer Health |
Anadin |
Analgesics |
Spink Consumer Relations |
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...